Delivery Order SPE2DB20D6035-SPE2DB24FD2HE
- Not listed
- This federal contract award, valued at $7,207.68, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of droxidopa 100 mg capsules, a medication used to treat certain neurological conditions. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running...
- This federal contract award, valued at $4,030.23, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,115,953 units of the prescription medication droxidopa 100 mg capsules. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of May 5, 2025. It is not designated as a set-aside contract, indicating open...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Droxidopa 100 mg capsules, a specialty medication, with a ceiling value of $9,792.00 and a period of performance through December 14, 2023. This award is a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- The U.S. Defense Logistics Agency (DLA) awarded a $13,920.91 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 90-count packages of the drug DROXIDOPA 100 MG CAPSULE. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, which provides a comprehensive range of pharmaceutical products and medical supplies to support military...
- The Defense Logistics Agency awarded a delivery order valued at $15,201.48 to AmerisourceBergen Drug Corp for the supply of Droxidopa 100 mg capsules (90-count) on December 15, 2025, with an ultimate completion date of December 16, 2025. This is a firm fixed-price, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- This federal contract award, with ID SPE2DB20D3303|SPE2DB25FY8J9, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $7,008.41 firm fixed-price delivery order contract is for the supply of 4566929688 - DROXIDOPA 300 MG CAPSULE 90S. The ultimate completion date for this contract is January 15, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has established itself as a key vendor...
- The Defense Logistics Agency awarded a $85,610.71 delivery order to AmerisourceBergen Drug Corp for the supply of Droxidopa 200 mg capsules (90-count units) under a firm fixed-price contract. The award, issued on November 6, 2025, with completion targeted for November 7, 2025, represents a competitive procurement with no set-aside designation. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania will serve as the place of performance for this pharmaceutical delivery order. This...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Department of Defense Medical Supply Chain on September 29, 2025, for the supply of Droxidopa 100 mg capsules (90-count units) valued at $26,921.20. This award is a firm fixed-price delivery order with no set-aside designation, indicating the contract was competitively awarded. The order is scheduled for completion by September 30, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- This federal contract award, identified as SPE2DB25D3018|SPE2DB25FUXMP, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,568,236,364 units of DROXIDOPA 300 MG CAPSULE 90S, a medication, with a ceiling value of $28,310.61. The contract is a firm fixed-price arrangement with a period of performance extending to May 14, 2025. Amerisourcebergen...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, received a firm fixed-price delivery order from the Defense Logistics Agency (DLA) valued at $67,481 for the supply of Droxidopa 100 mg capsules (90-count units). The contract was awarded on December 1, 2025, with an ultimate completion date of December 2, 2025, and was not designated as a set-aside procurement. This delivery order represents a single requisition fulfilled under AmerisourceBergen's larger Indefinite...
- SPE2DB20D6035Indefinite Delivery Contract
- SPE2DB20D6035-SPE2DB24FD2HEDelivery Order
This federal contract award is for the delivery of 100 mg capsules of the prescription drug droxidopa, with a ceiling value of $5,160.66 and a completion date of June 17, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. This contract is a delivery order placed under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the Defense Logistics Agency (DLA) Troop Support Medical, valued up to $999,999,999.00 through December 2025. The DLA IDC enables the agency to efficiently procure essential medical commodities, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials, to support military treatment programs and facilities worldwide. This specific contract award does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.2k | 6/14/24 |